Literature DB >> 24178858

History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease).

Anne-Caroline Chany1, Cédric Tresse, Virginie Casarotto, Nicolas Blanchard.   

Abstract

Mycobacterium ulcerans infections (Buruli ulcer disease) have a long history that can be traced back 150 years. The successive discoveries of the mycobacteria in 1948 and of mycolactone A/B in 1999, the toxin responsible for this dramatic necrotic skin disease, resulted in a paradigm shift concerning the disease itself and in a broader sense, delineated an entirely new role for bioactive polyketides as virulence factors. The fascinating history, biology and chemistry of M. ulcerans infections are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24178858     DOI: 10.1039/c3np70068b

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  13 in total

1.  Mycolactone Toxin Membrane Permeation: Atomistic versus Coarse-Grained MARTINI Simulations.

Authors:  Fikret Aydin; Rui Sun; Jessica M J Swanson
Journal:  Biophys J       Date:  2019-05-21       Impact factor: 4.033

Review 2.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

Review 3.  HUMAN MICROBIOTA. Small molecules from the human microbiota.

Authors:  Mohamed S Donia; Michael A Fischbach
Journal:  Science       Date:  2015-07-23       Impact factor: 47.728

4.  Detection of Mycolactone by Thin Layer Chromatography.

Authors:  Richard Kwamla Amewu; Thomas Spangenberg
Journal:  Methods Mol Biol       Date:  2022

5.  A need for null models in understanding disease transmission: the example of Mycobacterium ulcerans (Buruli ulcer disease).

Authors:  Joseph P Receveur; Alexandra Bauer; Jennifer L Pechal; Sophie Picq; Magdalene Dogbe; Heather R Jordan; Alex W Rakestraw; Kayla Fast; Michael Sandel; Christine Chevillon; Jean-François Guégan; John R Wallace; M Eric Benbow
Journal:  FEMS Microbiol Rev       Date:  2022-01-18       Impact factor: 15.177

6.  Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.

Authors:  Bryan E Hart; Laura P Hale; Sunhee Lee
Journal:  PLoS Negl Trop Dis       Date:  2015-09-22

7.  Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions.

Authors:  Joy Ogbechi; Marie-Thérèse Ruf; Belinda S Hall; Katherine Bodman-Smith; Moritz Vogel; Hua-Lin Wu; Alexander Stainer; Charles T Esmon; Josefin Ahnström; Gerd Pluschke; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

8.  The potent effect of mycolactone on lipid membranes.

Authors:  Milène Nitenberg; Anaïs Bénarouche; Ofelia Maniti; Estelle Marion; Laurent Marsollier; Julie Géan; Erick J Dufourc; Jean-François Cavalier; Stéphane Canaan; Agnès P Girard-Egrot
Journal:  PLoS Pathog       Date:  2018-01-10       Impact factor: 6.823

9.  Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans.

Authors:  Cesar A López; Clifford J Unkefer; Basil I Swanson; Jessica M J Swanson; S Gnanakaran
Journal:  PLoS Comput Biol       Date:  2018-02-05       Impact factor: 4.475

10.  Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.

Authors:  Bryan E Hart; Sunhee Lee
Journal:  PLoS Negl Trop Dis       Date:  2016-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.